ID   MATK_HUMAN              Reviewed;         507 AA.
AC   P42679; B3KNZ9; Q9NST8;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   15-MAR-2017, entry version 182.
DE   RecName: Full=Megakaryocyte-associated tyrosine-protein kinase;
DE            EC=2.7.10.2;
DE   AltName: Full=CSK homologous kinase;
DE            Short=CHK;
DE   AltName: Full=Hematopoietic consensus tyrosine-lacking kinase;
DE   AltName: Full=Protein kinase HYL;
DE   AltName: Full=Tyrosine-protein kinase CTK;
GN   Name=MATK; Synonyms=CTK, HYL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8134117;
RA   Sakano S., Iwama A., Inazawa J., Ariyama T., Ohno M., Suda T.;
RT   "Molecular cloning of a novel non-receptor tyrosine kinase, HYL
RT   (hematopoietic consensus tyrosine-lacking kinase).";
RL   Oncogene 9:1155-1161(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Megakaryocyte;
RX   PubMed=8288563;
RA   Bennett B.D., Cowley S., Jiang S., London R., Deng B., Grabarek J.,
RA   Groopman J.E., Goeddel D.V., Avraham H.;
RT   "Identification and characterization of a novel tyrosine kinase from
RT   megakaryocytes.";
RL   J. Biol. Chem. 269:1068-1074(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7530249; DOI=10.1074/jbc.270.4.1833;
RA   Avraham S., Jiang S., Ota S., Fu Y., Deng B., Dowler L.L., White R.A.,
RA   Avraham H.;
RT   "Structural and functional studies of the intracellular tyrosine
RT   kinase MATK gene and its translated product.";
RL   J. Biol. Chem. 270:1833-1842(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   CHARACTERIZATION.
RX   PubMed=7936664;
RA   Hamaguchi I., Iwama A., Yamaguchi N., Sakano S., Matsuda Y., Suda T.;
RT   "Characterization of mouse non-receptor tyrosine kinase gene, HYL.";
RL   Oncogene 9:3371-3374(1994).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Platelet;
RX   PubMed=9171348; DOI=10.1093/emboj/16.9.2342;
RA   Hirao A., Hamaguchi I., Suda T., Yamaguchi N.;
RT   "Translocation of the Csk homologous kinase (Chk/Hyl) controls
RT   activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated
RT   platelets.";
RL   EMBO J. 16:2342-2351(1997).
RN   [11]
RP   INTERACTION WITH KIT.
RX   PubMed=9038210; DOI=10.1074/jbc.272.9.5915;
RA   Price D.J., Rivnay B., Fu Y., Jiang S., Avraham S., Avraham H.;
RT   "Direct association of Csk homologous kinase (CHK) with the
RT   diphosphorylated site Tyr568/570 of the activated c-KIT in
RT   megakaryocytes.";
RL   J. Biol. Chem. 272:5915-5920(1997).
RN   [12]
RP   REVIEW ON ROLE IN KIT SIGNALING.
RX   PubMed=16129412; DOI=10.1016/j.bbrc.2005.08.055;
RA   Roskoski R. Jr.;
RT   "Signaling by Kit protein-tyrosine kinase--the stem cell factor
RT   receptor.";
RL   Biochem. Biophys. Res. Commun. 337:1-13(2005).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-501, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-501, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   STRUCTURE BY NMR OF 39-108.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structures of the SH3 domain of human megakaryocyte-
RT   associated tyrosine-protein kinase.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [20]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-354; THR-496 AND GLN-503.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Could play a significant role in the signal transduction
CC       of hematopoietic cells. May regulate tyrosine kinase activity of
CC       SRC-family members in brain by specifically phosphorylating their
CC       C-terminal regulatory tyrosine residue which acts as a negative
CC       regulatory site. It may play an inhibitory role in the control of
CC       T-cell proliferation. {ECO:0000269|PubMed:9171348}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- SUBUNIT: Interacts with KIT. {ECO:0000269|PubMed:9038210}.
CC   -!- INTERACTION:
CC       P10275:AR; NbExp=4; IntAct=EBI-751664, EBI-608057;
CC       P04626:ERBB2; NbExp=2; IntAct=EBI-751664, EBI-641062;
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-751664, EBI-352572;
CC       Q5S007:LRRK2; NbExp=2; IntAct=EBI-751664, EBI-5323863;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9171348}.
CC       Membrane {ECO:0000269|PubMed:9171348}. Note=In platelets, 90% of
CC       MATK localizes to the membrane fraction, and translocates to the
CC       cytoskeleton upon thrombin stimulation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P42679-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P42679-2; Sequence=VSP_043123;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P42679-3; Sequence=VSP_044277;
CC   -!- TISSUE SPECIFICITY: Expressed in various myeloid cell lines,
CC       detected in brain and lung.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. CSK subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L18974; AAA16703.1; -; mRNA.
DR   EMBL; X77278; CAA54493.1; -; mRNA.
DR   EMBL; S75164; AAC60645.1; -; Genomic_DNA.
DR   EMBL; S75145; AAC60645.1; JOINED; Genomic_DNA.
DR   EMBL; S75147; AAC60645.1; JOINED; Genomic_DNA.
DR   EMBL; S75166; AAC60645.1; JOINED; Genomic_DNA.
DR   EMBL; S75168; AAC60645.1; JOINED; Genomic_DNA.
DR   EMBL; S75151; AAC60645.1; JOINED; Genomic_DNA.
DR   EMBL; S75153; AAC60645.1; JOINED; Genomic_DNA.
DR   EMBL; S75155; AAC60645.1; JOINED; Genomic_DNA.
DR   EMBL; S75156; AAC60645.1; JOINED; Genomic_DNA.
DR   EMBL; S75158; AAC60645.1; JOINED; Genomic_DNA.
DR   EMBL; S75159; AAC60645.1; JOINED; Genomic_DNA.
DR   EMBL; S75162; AAC60645.1; JOINED; Genomic_DNA.
DR   EMBL; AK055395; BAG51511.1; -; mRNA.
DR   EMBL; AL137754; CAB70906.2; -; mRNA.
DR   EMBL; AC005777; AAC62843.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW69285.1; -; Genomic_DNA.
DR   EMBL; BC000114; AAH00114.1; -; mRNA.
DR   EMBL; BC003109; AAH03109.1; -; mRNA.
DR   CCDS; CCDS12113.1; -. [P42679-2]
DR   CCDS; CCDS12114.1; -. [P42679-1]
DR   CCDS; CCDS42468.1; -. [P42679-3]
DR   PIR; A49865; A49865.
DR   PIR; A55625; A55625.
DR   RefSeq; NP_002369.2; NM_002378.3. [P42679-2]
DR   RefSeq; NP_647611.1; NM_139354.2. [P42679-3]
DR   RefSeq; NP_647612.1; NM_139355.2. [P42679-1]
DR   RefSeq; XP_011526320.1; XM_011528018.1. [P42679-1]
DR   UniGene; Hs.631845; -.
DR   PDB; 1JWO; X-ray; 2.50 A; A=117-213.
DR   PDB; 1X6G; NMR; -; A=41-108.
DR   PDB; 3US4; X-ray; 1.50 A; A=117-213.
DR   PDBsum; 1JWO; -.
DR   PDBsum; 1X6G; -.
DR   PDBsum; 3US4; -.
DR   ProteinModelPortal; P42679; -.
DR   SMR; P42679; -.
DR   BioGrid; 110315; 14.
DR   IntAct; P42679; 11.
DR   MINT; MINT-1466004; -.
DR   STRING; 9606.ENSP00000378485; -.
DR   BindingDB; P42679; -.
DR   ChEMBL; CHEMBL4175; -.
DR   GuidetoPHARMACOLOGY; 2101; -.
DR   iPTMnet; P42679; -.
DR   PhosphoSitePlus; P42679; -.
DR   BioMuta; MATK; -.
DR   DMDM; 1169123; -.
DR   EPD; P42679; -.
DR   MaxQB; P42679; -.
DR   PaxDb; P42679; -.
DR   PeptideAtlas; P42679; -.
DR   PRIDE; P42679; -.
DR   DNASU; 4145; -.
DR   Ensembl; ENST00000310132; ENSP00000308734; ENSG00000007264. [P42679-1]
DR   Ensembl; ENST00000395040; ENSP00000378481; ENSG00000007264. [P42679-3]
DR   Ensembl; ENST00000395045; ENSP00000378485; ENSG00000007264. [P42679-2]
DR   Ensembl; ENST00000619596; ENSP00000483213; ENSG00000007264. [P42679-2]
DR   GeneID; 4145; -.
DR   KEGG; hsa:4145; -.
DR   UCSC; uc002lyt.4; human. [P42679-1]
DR   CTD; 4145; -.
DR   DisGeNET; 4145; -.
DR   GeneCards; MATK; -.
DR   HGNC; HGNC:6906; MATK.
DR   HPA; HPA004847; -.
DR   MIM; 600038; gene.
DR   neXtProt; NX_P42679; -.
DR   OpenTargets; ENSG00000007264; -.
DR   PharmGKB; PA30649; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000119011; -.
DR   HOGENOM; HOG000233858; -.
DR   HOVERGEN; HBG008761; -.
DR   InParanoid; P42679; -.
DR   KO; K08888; -.
DR   PhylomeDB; P42679; -.
DR   TreeFam; TF351634; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-8863795; Downregulation of ERBB2 signaling.
DR   SignaLink; P42679; -.
DR   SIGNOR; P42679; -.
DR   EvolutionaryTrace; P42679; -.
DR   GeneWiki; Megakaryocyte-associated_tyrosine_kinase; -.
DR   GenomeRNAi; 4145; -.
DR   PRO; PR:P42679; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000007264; -.
DR   CleanEx; HS_MATK; -.
DR   ExpressionAtlas; P42679; baseline and differential.
DR   Genevisible; P42679; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc.
DR   GO; GO:0005102; F:receptor binding; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0038128; P:ERBB2 signaling pathway; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0007498; P:mesoderm development; TAS:ProtInc.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IBA:GO_Central.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Kinase; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; SH2 domain; SH3 domain; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN         1    507       Megakaryocyte-associated tyrosine-protein
FT                                kinase.
FT                                /FTId=PRO_0000088073.
FT   DOMAIN       58    110       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      122    211       SH2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      235    482       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     241    249       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    352    352       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     262    262       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     501    501       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     41       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_044277.
FT   VAR_SEQ       1     24       MAGRGSLVSWRAFHGCDSAEELPR -> MQGHFPAERREGR
FT                                PRRGTRGQQQLL (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043123.
FT   VARIANT     354    354       A -> T (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041679.
FT   VARIANT     496    496       A -> T (in dbSNP:rs35351680).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041680.
FT   VARIANT     503    503       R -> Q (in a colorectal adenocarcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs778726488).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041681.
FT   CONFLICT    107    108       ER -> DG (in Ref. 1; AAA16703).
FT                                {ECO:0000305}.
FT   CONFLICT    400    400       Missing (in Ref. 1; AAA16703).
FT                                {ECO:0000305}.
FT   CONFLICT    466    507       ARRPPFRKLAEKLARELRSAGAPASVSGQDADGSTSPRSQE
FT                                P -> PAGHPSANWPRSWPGSYAVQVPQPPSQGRTPTVHLA
FT                                PKPGALTPPGGPWPQRTERVESAAWGH (in Ref. 1;
FT                                AAA16703). {ECO:0000305}.
FT   STRAND       52     57       {ECO:0000244|PDB:1X6G}.
FT   STRAND       59     61       {ECO:0000244|PDB:1X6G}.
FT   STRAND       74     79       {ECO:0000244|PDB:1X6G}.
FT   STRAND       83     91       {ECO:0000244|PDB:1X6G}.
FT   TURN         92     94       {ECO:0000244|PDB:1X6G}.
FT   STRAND       97    101       {ECO:0000244|PDB:1X6G}.
FT   HELIX       102    104       {ECO:0000244|PDB:1X6G}.
FT   STRAND      105    107       {ECO:0000244|PDB:1X6G}.
FT   STRAND      123    126       {ECO:0000244|PDB:1JWO}.
FT   HELIX       129    135       {ECO:0000244|PDB:3US4}.
FT   STRAND      144    148       {ECO:0000244|PDB:3US4}.
FT   STRAND      150    152       {ECO:0000244|PDB:3US4}.
FT   STRAND      156    162       {ECO:0000244|PDB:3US4}.
FT   STRAND      165    174       {ECO:0000244|PDB:3US4}.
FT   STRAND      177    188       {ECO:0000244|PDB:3US4}.
FT   HELIX       189    198       {ECO:0000244|PDB:3US4}.
FT   STRAND      203    205       {ECO:0000244|PDB:3US4}.
SQ   SEQUENCE   507 AA;  56469 MW;  85721C6E024575EF CRC64;
     MAGRGSLVSW RAFHGCDSAE ELPRVSPRFL RAWHPPPVSA RMPTRRWAPG TQCITKCEHT
     RPKPGELAFR KGDVVTILEA CENKSWYRVK HHTSGQEGLL AAGALREREA LSADPKLSLM
     PWFHGKISGQ EAVQQLQPPE DGLFLVRESA RHPGDYVLCV SFGRDVIHYR VLHRDGHLTI
     DEAVFFCNLM DMVEHYSKDK GAICTKLVRP KRKHGTKSAE EELARAGWLL NLQHLTLGAQ
     IGEGEFGAVL QGEYLGQKVA VKNIKCDVTA QAFLDETAVM TKMQHENLVR LLGVILHQGL
     YIVMEHVSKG NLVNFLRTRG RALVNTAQLL QFSLHVAEGM EYLESKKLVH RDLAARNILV
     SEDLVAKVSD FGLAKAERKG LDSSRLPVKW TAPEALKHGK FTSKSDVWSF GVLLWEVFSY
     GRAPYPKMSL KEVSEAVEKG YRMEPPEGCP GPVHVLMSSC WEAEPARRPP FRKLAEKLAR
     ELRSAGAPAS VSGQDADGST SPRSQEP
//
